Annual Shareholders Equity
$257.80 M
+$2.07 M+0.81%
December 31, 2023
Summary
- As of February 8, 2025, COGT annual stockholders equity is $257.80 million, with the most recent change of +$2.07 million (+0.81%) on December 31, 2023.
- During the last 3 years, COGT annual shareholders equity has risen by +$23.14 million (+9.86%).
- COGT annual shareholders equity is now at all-time high.
Performance
COGT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$314.66 M
-$58.56 M-15.69%
September 30, 2024
Summary
- As of February 8, 2025, COGT quarterly stockholders equity is $314.66 million, with the most recent change of -$58.56 million (-15.69%) on September 30, 2024.
- Over the past year, COGT quarterly shareholders equity has dropped by -$58.56 million (-15.69%).
- COGT quarterly shareholders equity is now -25.50% below its all-time high of $422.33 million, reached on March 31, 2024.
Performance
COGT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
COGT Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.8% | -15.7% |
| 3 y3 years | +9.9% | +59.5% |
| 5 y5 years | +328.0% | +1535.4% |
COGT Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.4% | -25.5% | +67.5% |
| 5 y | 5-year | at high | +711.7% | -25.5% | +1535.4% |
| alltime | all time | at high | +810.8% | -25.5% | +1879.2% |
Cogent Biosciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $314.66 M(-15.7%) |
| Jun 2024 | - | $373.22 M(-11.6%) |
| Mar 2024 | - | $422.33 M(+63.8%) |
| Dec 2023 | $257.80 M(+0.8%) | $257.80 M(-14.9%) |
| Sep 2023 | - | $302.90 M(-13.1%) |
| Jun 2023 | - | $348.43 M(+55.9%) |
| Mar 2023 | - | $223.56 M(-12.6%) |
| Dec 2022 | $255.74 M(+19.4%) | $255.74 M(-11.8%) |
| Sep 2022 | - | $289.94 M(-9.2%) |
| Jun 2022 | - | $319.38 M(+70.0%) |
| Mar 2022 | - | $187.86 M(-12.3%) |
| Dec 2021 | $214.18 M | $214.18 M(+8.6%) |
| Sep 2021 | - | $197.24 M(-7.3%) |
| Jun 2021 | - | $212.80 M(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $226.76 M(-3.4%) |
| Dec 2020 | $234.67 M(+638.8%) | $234.67 M(+102.2%) |
| Sep 2020 | - | $116.06 M(+503.2%) |
| Jun 2020 | - | $19.24 M(-25.1%) |
| Mar 2020 | - | $25.70 M(-19.1%) |
| Dec 2019 | $31.76 M(-47.3%) | $31.76 M(+11.0%) |
| Sep 2019 | - | $28.62 M(-28.0%) |
| Jun 2019 | - | $39.76 M(-34.0%) |
| Dec 2018 | $60.23 M(+112.8%) | $60.23 M(-10.8%) |
| Sep 2018 | - | $67.53 M(-11.9%) |
| Jun 2018 | - | $76.67 M(+382.3%) |
| Mar 2018 | - | $15.90 M(-43.8%) |
| Dec 2017 | $28.30 M(-46.0%) | $28.30 M |
| Dec 2016 | $52.39 M | - |
FAQ
- What is Cogent Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Cogent Biosciences?
- What is Cogent Biosciences annual shareholders equity year-on-year change?
- What is Cogent Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Cogent Biosciences?
- What is Cogent Biosciences quarterly shareholders equity year-on-year change?
What is Cogent Biosciences annual stockholders equity?
The current annual shareholders equity of COGT is $257.80 M
What is the all time high annual shareholders equity for Cogent Biosciences?
Cogent Biosciences all-time high annual stockholders equity is $257.80 M
What is Cogent Biosciences annual shareholders equity year-on-year change?
Over the past year, COGT annual stockholders equity has changed by +$2.07 M (+0.81%)
What is Cogent Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of COGT is $314.66 M
What is the all time high quarterly shareholders equity for Cogent Biosciences?
Cogent Biosciences all-time high quarterly stockholders equity is $422.33 M
What is Cogent Biosciences quarterly shareholders equity year-on-year change?
Over the past year, COGT quarterly stockholders equity has changed by -$58.56 M (-15.69%)